🔎 Trials Near Me

Home › Pulmonary Hypertension › Illinois

Pulmonary Hypertension clinical trials in Illinois

6 studies for Pulmonary Hypertension are looking for participants at sites in Illinois.

Cities in Illinois

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Northwestern University, Chicago
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Chicago
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Northwestern University, Chicago
  • University of Illinois Health, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Northwestern University, Chicago
  • Loyola University Medical Center, Maywood
  • Advocate Christ Medical Center, Oak Lawn
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

  • Prairie Cardiovascular, O'Fallon
  • Prairie Education & Research Cooperative, Springfield
  • St Johns Hospital, Springfield, Springfield
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07087613

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • University of Chicago, Chicago
  • Advocate Health & Hospitals Corporation, Oakbrook Terrace
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.